EUVIMEDEUVIMED entdecken
Crossref

Covid long : de quoi parle-t-on ?

Médecine · 2022

DOI: 10.1684/med.2022.735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Médecine, 2022.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In most cases, the signs of COVID-19 disappear completely within two to three weeks, but some patients, whether they have been hospitalized or not, can experience symptoms that last well beyond this timeframe and cannot be associated with another illness. Current evidence suggests that approximately 10 to 20 percent of these individuals subsequently experience a variety of medium- to long-term effects. These medium- and long-term effects are then referred to as post-COVID-19 illness or “long-term COVID-19.” But what do we know about these prolonged symptoms of COVID-19, and what is long COVID?

Zitieren

APA

(2022). Covid long : de quoi parle-t-on ?. Médecine. https://doi.org/10.1684/med.2022.735

Vancouver

Covid long : de quoi parle-t-on ?. Médecine. 2022. doi:10.1684/med.2022.735

BibTeX
@article{euvimed2022,
  title = {Covid long : de quoi parle-t-on ?},
  journal = {Médecine},
  year = {2022},
  doi = {10.1684/med.2022.735}
}
Kostenlos starten →